Owori Mang'eni
Payments from drug & device makers
Across 60 payments — averaging $34.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ceribell, Inc.$572
- AbbVie$283
- UCB, Inc.$159
- Biogen$127
- Mallinckrodt Hospital Products Inc.$124
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$112
- plus $713 from 18 others
What the payments were for
- Travel & lodging$50024%
- Food & beverage$1,59176%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ceribell, Inc. | 2 | $572 |
| AbbVie(2 entities) | 10 | $283 |
| UCB, Inc. | 6 | $159 |
| Biogen | 6 | $127 |
| Mallinckrodt Hospital Products Inc. | 1 | $124 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $112 |
| Argenx US, Inc. | 4 | $100 |
| Pfizer | 4 | $82 |
| AstraZeneca(2 entities) | 4 | $66 |
| ANI Pharmaceuticals, Inc. | 2 | $63 |
| Lilly USA, LLC | 3 | $56 |
| Neurocrine Biosciences, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Neurelis, Inc. | 2 | $36 |
| Microtransponder, Inc. | 1 | $32 |
| Merz Pharmaceuticals, LLC | 2 | $32 |
| Novartis | 1 | $26 |
| Genentech USA, Inc. | 1 | $24 |
| Harmony Biosciences LLC | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
| Amgen | 1 | $13 |
| Banner Life Sciences, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ceribell Rapid Response EEG$500
- BOTOX$125
- TERLIVAZ$124
- XIFAXAN$112
How this compares
$2,091 in reported general payments places this provider in the 50th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 49 | $1,110 |
| Oxcarbazepine | 14 | $740 |
| Levetiracetam | 36 | $575 |
| Gabapentin | 48 | $322 |
| Memantine Hcl | 12 | $183 |
| Quetiapine Fumarate | 28 | $178 |
| Donepezil Hcl | 19 | $163 |
| Duloxetine Hcl | 11 | $155 |
| Escitalopram Oxalate | 18 | $51 |
| Atorvastatin Calcium | 13 | $49 |
| Topiramate | 12 | $41 |
| Trazodone Hcl | 16 | $32 |
| Clonazepam | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other neurology in Salem
- Michelle BetzVirginia Beach$3.3M
- Daniel CohenNorfolk$2.9M
- Heidi CraytonVienna$2.5M
- Ramsey FalconerAlexandria$2.4M
- Robert ShinCharlottesville$2.2M
- Simon FishmanAlexandria$1.6M
- Ingrid Loma MillerNorfolk$1.2M
- Matthew BarrettHenrico$1.1M
- James BickselMc Lean$1M
- Rahul DaveFairfax$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.